Clinical trials
Withdrawn Phase 1/2 Respiratory Distress Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aveni Foundation | 1 |
| Baylx Inc. | 1 |
| Direct Biologics, LLC | 1 |
| Seattle Children's Hospital | 1 |
| The University of Texas Health Science Center at San Antonio | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Respiratory Distress Syndrome | 5 |
| COVID-19 | 3 |
| Acute Lung Injury | 1 |
| Cytokine Release Syndrome | 1 |
| Heart Defects, Congenital | 1 |
| Hypertension, Pulmonary | 1 |
| Persistent Fetal Circulation Syndrome | 1 |
| Respiratory Insufficiency | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.